MACROECONOMICS
Active advantage on short-term opportunities
Is flexibility the key to strong returns?
A dose of clarity for pharma investors
European pharmaceuticals have dodged steep tariff threats.
US PPI shock sends yields higher
Are inflation surprises putting rate cuts at risk?
Peace talks trigger defence stock slumps
Is the dip hiding defence’s long-term momentum?
Do rising rates mean now is the time for active investing?
Rate hikes have provided new opportunities for stock pickers.
Pharma stocks brace for pricing pressure following Trump ultimatums
How will pricing reforms reshape the sector?
Jobs slowdown fuels fixed income rally
How likely is a rate cut next month?
Who will benefit from the 'Big Beautiful Bill'?
The Act may provide an economic boost, but concerns remain over the government’s...
Undervalued stocks in Europe's defence drive
Which equities remain cheap despite the continent’s spending spree?
How EU-US trade deal validates recent rally
What long-term impact will tariffs have on equities?
Inflation continues to give investors the jitters
After a strong couple of years, macroeconomic factors have reduced investors’...
The return of risk-parity rebalancing?
How could this approach help investors in turbulent times? Professional...
